Setoodeh Soheila, Khorsand Marjan, Takhshid Mohammad Ali
School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Laboratory Sciences Department, Faculty of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
J Diabetes Metab Disord. 2020 Jun 3;19(2):767-774. doi: 10.1007/s40200-020-00560-x. eCollection 2020 Dec.
Serum lipids and glycemic dysregulation are the known characteristics of β- thalassemia major (β-TM). Here, we evaluated the association of these disorders with insulin resistance (IR), oxidative stress and serum ferritin values in patients with β-TM.
This case-control study was performed in thalassemia unite of Darab Hospital (Darab, Fars province, Iran) from December 2016 to December 2017. Forty-eight patients with β-TM and 33 healthy individuals were enrolled. Serum fasting blood sugar (FBS), insulin, total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL), ischemia modified albumin (IMA), and ferritin were measured. The values of HOMA-IR, LDL: TG ratio, atherogenic index (AI), atherogenic index of plasma (AIP), and coronary risk index (CRI) were calculated.
The level of serum ferritin, IMA, FBS, TG, AIP, LDL: TG ratio, and the prevalence of IR (HOMA-IR < 3.8) were significantly higher while TC, LDL-C, HDL-C, and AI were significantly lower in the patients compared to the control group. In patient with β-TM, serum ferritin revealed to have a positive association with serum insulin, HOMA-IR, AI, and CRI levels while serum IMA showed positive association with TG and AIP and inverse association with hypocholesterolemia. HOMA-IR had positive correlation with HDL levels.
Oxidative stress and iron overload are predictors of serum glycemic and lipid dysregulation, suggesting possible beneficial effect of antioxidants and efficient iron chelating therapy in reducing the risk of metabolic disorders in β- thalassemia.
血清脂质和血糖调节异常是重型β地中海贫血(β-TM)的已知特征。在此,我们评估了这些病症与β-TM患者胰岛素抵抗(IR)、氧化应激和血清铁蛋白值之间的关联。
本病例对照研究于2016年12月至2017年12月在达拉布医院(伊朗法尔斯省达拉布)的地中海贫血科进行。纳入了48例β-TM患者和33名健康个体。测量了血清空腹血糖(FBS)、胰岛素、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、缺血修饰白蛋白(IMA)和铁蛋白。计算了HOMA-IR、LDL:TG比值、动脉粥样硬化指数(AI)、血浆动脉粥样硬化指数(AIP)和冠心病风险指数(CRI)的值。
与对照组相比,患者的血清铁蛋白、IMA、FBS、TG、AIP、LDL:TG比值水平以及IR患病率(HOMA-IR<3.8)显著更高,而TC、LDL-C、HDL-C和AI显著更低。在β-TM患者中,血清铁蛋白与血清胰岛素、HOMA-IR、AI和CRI水平呈正相关,而血清IMA与TG和AIP呈正相关,与低胆固醇血症呈负相关。HOMA-IR与HDL水平呈正相关。
氧化应激和铁过载是血清血糖和脂质调节异常的预测因素,提示抗氧化剂和有效的铁螯合疗法在降低β地中海贫血代谢紊乱风险方面可能具有有益作用。